Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.800
-0.030 (-1.06%)
At close: Mar 9, 2026, 4:00 PM EDT
2.900
+0.100 (3.57%)
After-hours: Mar 9, 2026, 7:08 PM EDT
Processa Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6 | 3 | 8 | 18 | 77 | 70 | |
| Market Cap Growth | 252.45% | -64.97% | -53.14% | -77.16% | 10.51% | -29.44% | |
| Enterprise Value | 0 | 0 | 2 | 9 | 58 | 71 | |
| Last Close Price | 2.80 | 22.09 | 167.30 | 550.00 | 2450.00 | 3297.50 | |
| PB Ratio | 1.01 | 1.70 | 1.65 | 2.35 | 3.02 | 3.04 | |
| P/TBV Ratio | 1.09 | 1.70 | 1.65 | 2.35 | 4.42 | 4.94 | |
| Debt / Equity Ratio | - | 0.04 | 0.03 | 0.03 | 0.00 | 0.01 | |
| Net Debt / Equity Ratio | -1.08 | -0.66 | -0.91 | -0.84 | -0.64 | -0.66 | |
| Net Debt / EBITDA Ratio | 0.49 | 0.09 | 0.40 | 0.32 | 1.52 | 2.68 | |
| Net Debt / FCF Ratio | 0.59 | 0.10 | 0.56 | 0.65 | 1.88 | 4.80 | |
| Quick Ratio | 3.61 | 0.78 | 6.44 | 6.51 | 17.06 | 12.82 | |
| Current Ratio | 3.76 | 1.22 | 7.71 | 8.40 | 18.87 | 13.27 | |
| Return on Equity (ROE) | -270.74% | -354.51% | -178.52% | -166.43% | -47.20% | -93.14% | |
| Return on Assets (ROA) | -129.94% | -167.08% | -99.41% | -72.17% | -27.98% | -22.29% | |
| Return on Capital Employed (ROCE) | -223.20% | -710.30% | -226.60% | -265.80% | -45.40% | -26.80% | |
| Earnings Yield | -203.87% | -410.42% | -134.94% | -155.91% | -14.84% | -20.69% | |
| FCF Yield | -169.17% | -389.58% | -97.87% | -54.61% | -11.32% | -4.51% | |
| Buyback Yield / Dilution | -669.62% | -133.30% | -62.83% | -5.16% | -104.27% | -35.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.